Presenting at CPHI Japan

2023/02/20

2023年4月19～21日に東京ビッグサイトで開催される医薬品開発の総合展CPHI Japanで、当社、取締役CSOの梅津が講演を行います。

https://www.informa-japan.com/cphifcj/seminar/index.php?category=88#6A-08

RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs

RevolKa Started joint research of a drug discovery program for rare diseases

RevolKa launched a drug discovery program for rare diseases

Related Articles